Letybo (Korean Botox)
LetYbo is a botulinum toxin type A injectable product used for various cosmetic and medical purposes. It works by temporarily paralyzing or weakening targeted muscles, reducing the appearance of wrinkles and fine lines. Unlike Botox and Dysport, LetYbo has unique characteristics that set it apart. The FDA approved LetYbo based on evidence from three clinical trials of 1,271 patients with moderate to severe wrinkles between the eyebrows for efficacy and safety.
LetYbo is primarily used for aesthetic purposes, particularly in the treatment of facial wrinkles and lines, such as frown lines, forehead lines, crow's feet, and bunny lines. It can also be used to lift and contour eyebrows, slim the jawline, and soften neck bands. Store unopened Letybo vials in a refrigerator between 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze.
LetYbo is also utilized for non-surgical procedures such as hyperhidrosis, migraine headaches, and urinary incontinence. While it belongs to the same class of botulinum toxin type A products as Botox and Dysport, it distinguishes itself through its unique formulation and molecular structure. This distinction may result in variations in onset time, duration of effect, and diffusion patterns. Some practitioners and patients report that LetYbo may have a quicker onset of action and longer-lasting results compared to its counterparts. Additionally, LetYbo may offer a more natural and smoother appearance due to its diffusion properties.
LetYbo has just received FDA approval for cosmetic use in the United States, making it a viable option for patients seeking aesthetic enhancements. Its availability globally varies, with some regions having approved its use for cosmetic and medical applications. In the United States, LetYbo is typically administered by licensed healthcare professionals, including dermatologists, plastic surgeons, and certified injectors, ensuring safe and effective treatment outcomes.
LetYbo’s emergence underscores the ongoing pursuit of innovation in the quest for beauty and aesthetics, offering patients new possibilities. LETYBO is a promising addition to the arsenal of products available in the field of aesthetics and cosmetic medicine. Its unique properties and potential benefits make it an attractive option for patients looking to rejuvenate their appearance without surgery.
This is the latest toxin coming from Korean skincare. It is said to have a faster onset as little as 24 hours and lasts up to 4 months. This will be the 6th toxin to market starting with Botox Cosmetic, Xeomin, Dysport, Daxxify, and Jeuveau.
Top 11 Neurotoxins worldwide:
Botox (Allergan), Dysport (Galderma), Xeomin (Merz), Jeuveau (Evolus), Daxxify (Revance), Azzalure, Reloxin, Bocoture, PurTox, Neuronox and LetYbo.
